Amplify Bio Bets on AI×Bio, Welcomes Scientist-Turned-Founder Luke Riggan
sarahcat21 · x · 2026-11-06
Amplify Partners has welcomed Luke Riggan to its new life-science fund, Amplify Bio.
- Riggan earned his PhD at UCLA studying natural killer cells — how they persist and form memory — publishing in Nature Immunology, and has since gone from scientist to founder to investor.
- Amplify Bio's thesis: high-throughput biology plus powerful AI models, driven by a new generation of founders fluent in both computing and life sciences, is about to unlock a wave of innovation.
- The poster notes she learned more biology from Riggan's memos in a month than from decades growing up with a molecular biologist father.
More from Companies & People
- xAI inference and kernel engineer departs, citing SGLang, attention kernels and C++ inference stack rewrite — HanchungLee · 2026-11-06
- Meta looks abroad for data centers as AI firms scramble for compute — asusarla · 2026-11-06
- Jeff Dean teams with Laude Institute and top computer scientists to fund open science moonshots — JeffDean · 2026-11-06
- Defender argues Perplexity's Comet and memory system put it far ahead of rivals — ChrisUniverse · 2026-11-06
- Laid-off Microsoft manager making $320k can't find a job, runs out of money in 10 months — RexDouglass · 2026-11-06
- Fan Chung's classic research advice resurfaces: plenty of mistakes allowed, one win is enough — tianyin_xu · 2026-11-06